lactic acid has been researched along with Craniopharyngioma, Adamantinous in 3 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Poly(lactic-co-glycolic acid) microspheres loaded with imatinib mesylate has been developed as a new therapeutic strategy to prevent craniopharyngioma recurrence." | 7.79 | Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. ( Akgun, E; Avsar, T; Baysal, K; Karal-Yilmaz, O; Kilic, T; Kukut, M; Ozkan, A, 2013) |
| "Poly(lactic-co-glycolic acid) microspheres loaded with imatinib mesylate has been developed as a new therapeutic strategy to prevent craniopharyngioma recurrence." | 3.79 | Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. ( Akgun, E; Avsar, T; Baysal, K; Karal-Yilmaz, O; Kilic, T; Kukut, M; Ozkan, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karal-Yilmaz, O | 1 |
| Ozkan, A | 1 |
| Akgun, E | 1 |
| Kukut, M | 1 |
| Baysal, K | 1 |
| Avsar, T | 1 |
| Kilic, T | 1 |
| Arefyeva, IA | 1 |
| Semenova, JB | 1 |
| Zubairaev, MS | 1 |
| Kondrasheva, EA | 1 |
| Moshkin, AV | 1 |
| Cavallo, LM | 1 |
| Messina, A | 1 |
| Esposito, F | 1 |
| de Divitiis, O | 1 |
| Dal Fabbro, M | 1 |
| de Divitiis, E | 1 |
| Cappabianca, P | 1 |
1 trial available for lactic acid and Craniopharyngioma, Adamantinous
| Article | Year |
|---|---|
Skull base reconstruction in the extended endoscopic transsphenoidal approach for suprasellar lesions.
Topics: Biocompatible Materials; Bone Substitutes; Cranial Fossa, Posterior; Craniopharyngioma; Dura Mater; | 2007 |
2 other studies available for lactic acid and Craniopharyngioma, Adamantinous
| Article | Year |
|---|---|
Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis.
Topics: Antineoplastic Agents; Benzamides; Chromatography, High Pressure Liquid; Craniopharyngioma; Imatinib | 2013 |
Analysis of fluid in craniopharyngioma-related cysts in children: proteins, lactate and pH.
Topics: Adolescent; Albumins; Blood-Brain Barrier; Brain Diseases; Brain Neoplasms; Child; Child, Preschool; | 2002 |